What are bethanechol and mirabegron used for?
Bethanechol is a cholinergic drug (a muscarinic receptor agonist) used to help stimulate bladder contractions in conditions such as urinary retention due to reduced bladder contractility. It works on the bladder’s ability to squeeze and empty.
Mirabegron is a beta-3 adrenergic agonist used for overactive bladder symptoms like urgency, frequency, and urge incontinence by relaxing the bladder muscle to increase storage capacity rather than forcing emptying.
How do they work differently in the body?
Bethanechol increases cholinergic signaling to promote detrusor (bladder muscle) contraction and improve emptying when the bladder is underactive.
Mirabegron increases beta-3 signaling in the bladder, leading to relaxation during filling and less frequent or less urgent bladder contractions during the day and night.
Which one is better for urinary retention vs overactive bladder?
Bethanechol is generally the fit when the problem is weak bladder emptying (urinary retention or underactive bladder–type symptoms), because it targets contraction.
Mirabegron is generally the fit for overactive bladder symptoms (urgency, frequency, urge incontinence), because it targets storage/relaxation rather than squeezing the bladder empty.
If symptoms overlap, clinicians usually base the choice on the underlying mechanism (retention/underactive bladder versus overactivity/poor storage control).
What side effects do people usually ask about?
People taking bethanechol may experience cholinergic-type side effects such as abdominal cramping, diarrhea, sweating, or other effects linked to increased muscarinic activity.
People taking mirabegron may be concerned about blood pressure and heart-rate effects, since beta-adrenergic pathways can affect cardiovascular parameters, along with typical overactive-bladder medication tolerability issues.
Can mirabegron cause urinary retention?
Yes. Because mirabegron relaxes the bladder to improve storage, it can worsen emptying in some patients, especially those who already have impaired bladder contractility. That risk is why clinicians are cautious in people with a history of urinary retention or significant post-void residuals.
Can bethanechol worsen urgency or frequency?
Potentially. Because bethanechol is meant to increase detrusor contractions, it can aggravate urgency or cramping if the main issue is bladder overactivity rather than underactivity.
How do costs and insurance coverage compare?
Coverage varies widely by country, insurer, and whether the drug is brand or generic. Mirabegron is often priced higher than older generic options in some markets, while bethanechol availability and pricing vary depending on local formulary status. If you tell me your country and whether you have insurance, I can help you frame what to ask your pharmacy.
Key questions to decide between them with a clinician
- Is the dominant problem difficulty emptying (retention/large post-void residual) or overactive symptoms (urgency/frequency/urge incontinence)?
- Have you had bladder scans or post-void residual measurements?
- What are your baseline blood pressure and heart rate (relevant for mirabegron)?
- Are you on other medications that affect bladder function or heart rhythm?
Sources
I can answer more precisely about dosing, specific contraindications, and a side-effect comparison if you share what condition you’re treating (retention vs overactive bladder) and your age/sex and any heart or blood-pressure history.